Association of GP40/CD7+ acute myeloblastic leukemia and chromosome 5 aberrations.
Lutz
D
D
Ludwig Boltzmann-Institute for Leukemia Research and Hematology, Hanusch Hospital, Vienna, Austria.
Kasparu
H
H
Nowotny
H
H
Weber
E
E
Krieger
O
O
Köller
U
U
Tüchler
H
H
Knapp
W
W
D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D002869:Chromosome Aberrations; D002895:Chromosomes, Human, Pair 5 / Q000648:ultrastructure*; D004253:DNA Nucleotidylexotransferase / Q000032:analysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000235:genetics* / Q000276:immunology; D015479:Leukemia, Myelomonocytic, Acute / Q000235:genetics* / Q000276:immunology; D008562:Membrane Glycoproteins / Q000032:analysis*; D009363:Neoplasm Proteins / Q000032:analysis; D010641:Phenotype
D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C035267:glycoprotein 40 antigen, human; D004253:DNA Nucleotidylexotransferase